Lemaitre Vascular (LMAT) Asset Utilization Ratio (2011 - 2026)
Lemaitre Vascular's (LMAT) quarterly Asset Utilization Ratio came in at 0.41 in Q2 2026, little changed year-over-year from 0.41 in Q2 2025, and little changed quarter-over-quarter from 0.41 in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Asset Utilization Ratio for 16 consecutive years, with 0.41 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio changed 0.17% year-over-year to 0.41 in Q2 2026; TTM through Jun 2026 was 0.41, a 0.17% change from a year earlier, with the FY2025 full-year figure at 0.43, down 12.62% from the prior year.
- Asset Utilization Ratio was 0.41 for Q2 2026 at Lemaitre Vascular, roughly flat from 0.41 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.58 in Q3 2024 and troughed at 0.41 in Q1 2025.
- A 5-year average of 0.5 and a median of 0.54 in 2022 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio rose 7.69% in 2023 and fell 28.82% in 2025, its largest moves.
- Over 5 years, Asset Utilization Ratio stood at 0.53 in 2022, then gained by 7.69% to 0.57 in 2023, then fell by 16.71% to 0.47 in 2024, then declined by 13.12% to 0.41 in 2025, then grew by 0.48% to 0.41 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.41 (Q2 2026), 0.41 (Q1 2026), and 0.41 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 0.42 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 0.54 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 0.40 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 0.55 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 0.47 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 0.48 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.34 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 0.76 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 0.56 |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 0.41 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.41 |
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.41 |
| Dec 31, 2024 | 0.47 |
| Sep 30, 2024 | 0.58 |
| Jun 30, 2024 | 0.57 |
| Mar 31, 2024 | 0.57 |
| Dec 31, 2023 | 0.57 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.54 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.53 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.53 |
| Sep 30, 2021 | 0.57 |